Pharmaceuticals

Lucentis (Ranibizumab) Market Forecast 2026–2030 Presenting Long-Term Industry Insights

May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Lucentis (Ranibizumab) Market Expected To Reach Based On Its 2026 Value?

The lucentis (ranibizumab) market size has demonstrated significant growth in recent years. It is anticipated to expand from $3.74 million in 2025 to $3.96 million in 2026, achieving a compound annual growth rate (CAGR) of 5.7%. This historical growth can be linked to factors such as successful clinical outcomes in macular degeneration treatment, an increase in diabetic retinopathy instances, the expanding aging demographic, widespread adoption by ophthalmologists, and various regulatory approvals in the eye care sector.

The lucentis (ranibizumab) market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $4.87 million by 2030, demonstrating a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the forecast period stems from factors such as an increase in the prevalence of retinal diseases, improved accessibility to eye care services, the broadening scope of biosimilar competition, a heightened focus on early diagnosis, and technological innovations in injection delivery. Dominant trends within this timeframe include the sustained application of anti-VEGF therapies, a rise in the treatment of retinal vascular disorders, an increasing inclination towards intravitreal injections, the establishment of more ophthalmology specialty clinics, and an enhanced dedication to preserving vision.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19907&type=smp

What Leading Drivers Are Supporting The Lucentis (Ranibizumab) Market Expansion?

The Lucentis (ranibizumab) market is anticipated to expand due to the increasing incidence of eye-related conditions. These disorders encompass various diseases that impact vision and compromise ocular function. The growing occurrence of these conditions stems from factors such as aging, genetic predispositions, unhealthy lifestyle choices like smoking and poor diet, and environmental influences including prolonged exposure to sunlight or digital screens. Lucentis operates by blocking vascular endothelial growth factor (VEGF), a protein known for causing irregular blood vessel formation and leakage in the retina, a primary contributor to ailments such as age-related macular degeneration (AMD) and diabetic macular edema (DME). For instance, the National Eye Institute, a US government body, projected in 2024 that 2.2 million Americans will face blindness by 2030. Consequently, the rising prevalence of eye-related disorders is a key impetus for the growth of the Lucentis (ranibizumab) market.

What Are The Key Segment Divisions In The Lucentis (Ranibizumab) Market Segment Structure?

The lucentis (ranibizumab) market covered in this report is segmented –

1) By Type: Single-use Prefilled Syringe, Single-use Glass Vial

2) By Application: Age-related Macular Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, Myopic Choroidal Neovascularization, Uveitis

3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Which Trends Are Impacting The Progress Of The Lucentis (Ranibizumab) Market?

Leading companies within the Lucentis (ranibizumab) market are concentrating on the development of biosimilars to offer more budget-friendly alternatives to the original branded medication. Biosimilars are biological medical products that exhibit high similarity to an already approved reference biologic concerning their structure, effectiveness, and safety, without any significant clinical differences. For example, in April 2024, Formycon AG, a Germany-based biotechnology firm, and Bioeq AG, a Switzerland-based biotechnology firm, introduced their biosimilar form of Lucentis (ranibizumab), identified as FYB201, in Canada and Switzerland. Health Canada granted marketing authorization for the biosimilar under the designation Ranopto, while Swiss Medic approved it using the name Ranivisio. The approval and subsequent introduction of FYB201 aim to furnish more economical treatment choices for individuals affected by retinal diseases. It functions by inhibiting vascular endothelial growth factor A (VEGF-A), a protein that encourages abnormal blood vessel development in the retina, which can lead to swelling, leakage, and diminished vision.

Which Organizations Are Engaged In The Lucentis (Ranibizumab) Market?

Major companies operating in the lucentis (ranibizumab) market are F.Hoffmann-La Roche Ltd, Novartis AG

Get The Full Lucentis (Ranibizumab) Market Report:

https://www.thebusinessresearchcompany.com/report/lucentis-ranibizumab-global-market-report

Which Region Leads The Lucentis (Ranibizumab) Market In Terms Of Market Share?

North America was the largest region in the lucentis (ranibizumab) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lucentis (ranibizumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lucentis (Ranibizumab) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lucentis-ranibizumab-global-market-report

Browse Through More Reports Similar to the Global Lucentis (Ranibizumab) Market 2026, By The Business Research Company

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Financial Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795